The Hematological Deterioration and its Influences to the Human Body During Cardiopulmonary Bypass
The Hematological Deterioration and its Influences to the Human Body During Cardiopulmonary Bypass
批准号:
01480340
负责人:
EGUCHI Shoji
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The study is composed of the injury and reactions by each blood components such as leukocyte, platelet, coagulant factors, complement and other serum active proteins during cardiopulmonary bypass.Following data was obtained form clinical cardiopulmonary bypass in our hospital and experimental mock circulation with artificial lung.1. Accession of coagulation cascade and consumption of each coagulant factors were observed and finally thrombin-antithrombin III complex increased in circulating blood after clinical cardiopulmonary bypass. Activation of kininogen and prekalikrein followed by decreasing fibrinogen in mock circuits with normal temperature.2. Fibrinolytic process with increased plasmin-d_2plasmin inhibitor complex was always observed in clinical cardiopulmonary bypass circulation, otherwise, mild fibrinolysis occurred in mock circulation.3. The platelet counts decreased immediately after cardiopulmonary bypass in both clinical and experimental circulation and subsequent increasing possibly due to mobilization from pooled platelets in clinical circulation.platelet aggregation activity was strongly suppressed in both circulation and need several days to get normal activity in clinical cases.4. Polymorphonuclear leukocyte counts initially decreased during the hypothermic anoxic arrest and markedly increased after rewarming. Serum levels of neutrophil elastase significantly rose during CPB and superoxide anion was more generated after CPB.5. Both complement factor 4 and 3 were activated during CPB under following circumstances ex. hypothermia or normothermia, in clinical or mock circuits.Some drugs would be applied to diminish the hematological change and influence to the human body.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K Togashi et al: "The effect of blood transfusion upon the immune response in the early phase of the patients underwent open heart surgery" Jpn J Thorac Cardiovasc Surg. 36 :. 448-453, (1988)
K Togashi 等人:“输血对接受心脏直视手术的患者早期免疫反应的影响”Jpn J Thorac Cardiovasc Surg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
富樫賢一: "開心術時の放射線照射血輸血が細胞性免疫反応に及ぼす影響" 日本胸部外科学会雑誌. 37. 1958-1964 (1989)
Kenichi Togashi:“心脏直视手术期间辐照输血对细胞免疫反应的影响”日本胸外科学会杂志 37。1958-1964(1989)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K Togashi et al: "Complement activation during cardiopulmonary bypass : mechanism and prevention" Kyobu Geka. 42 :. 529-532, (1989)
K Togashi 等人:“体外循环期间的补体激活:机制和预防”Kyobu Geka。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
斉藤 憲: "ヘパリンコ-ティングチュ-ブとロ-ラポンプによる補助循環の臨床" 人工臓器. 19. 160-163 (1990)
Ken Saito:“使用肝素涂层管和滚子泵的临床辅助循环”人工器官。19. 160-163 (1990)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A Saito et al: "Clinical results of mechanical support using heparin-coated tube and roller pump system" Jpn J Artif Organs. 19 :. 160-163, (1990)
A Saito 等人:“使用肝素涂层管和滚子泵系统进行机械支持的临床结果”Jpn J Artif Organs。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Developement of Novel Synthetic Blocks with Unique Structure and Their Application to Molecular Design of Bioactive Molecules
-
批准号:07555285
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$9.73万
-
财政年份:1995
-
负责人:EGUCHI Shoji
-
依托单位:
Development of new immunosuppressive methods for organ transplantation targetting recognition of antigen and adhesive molecule
-
批准号:06454399
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1994
-
负责人:EGUCHI Shoji
-
依托单位:
SYNTHETIC DESIGN OF FUNCTIONAL HETEROPOLYCYCLES AND THEIR APPLICATION
-
批准号:04403017
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$22.66万
-
财政年份:1992
-
负责人:EGUCHI Shoji
-
依托单位:
Development of Novel Organic Fine Chemicals based on Polycycles
-
批准号:02555174
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$8.13万
-
财政年份:1990
-
负责人:EGUCHI Shoji
-
依托单位:
海外基金